Eastman Chemical EMN
$58.77 −$2.94 (-4.76%)
Market closed · Nov 20, 8:20 pm ET · Last extended-hours $58.90 +0.22%
Open$60.96
Prev close$61.71
Day range$58.51 – $61.80
Volume2.01M
Market cap$6.72B
P/E (TTM)10.8
Dividend yield5.72%
Fundamentals
Latest reported quarter: Q3, ended Sep 2026
Revenue$2.39B+8.3% YoY
Operating profit$315.00M+49.3% YoY
Net profit$253.00M+266.7% YoY
Diluted EPS$2.19+265.0% YoY
Free cash flow$195.00M-26.4% YoY
Operating cash flow$290.00M
Revenue, last 8 quarters
Net profit, last 8 quarters
Diluted EPS by quarter
Free cash flow by quarter
Annual revenue
Profitability & balance sheet
Gross margin20.6%
Operating margin11.0%
Net margin6.9%
Return on equity10.4%
Return on assets4.1%
Return on invested capital7.4%
Current ratio1.57
Liabilities / assets59.0%
Cash & investments$768.00M
Total debt$5.22B
Net cash (debt)-$4.45B
Free cash flow / sales5.2%
Where the revenue comes from
Quarter 2026/Q3
By business line
Income statement
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Revenue as Reported | $2.39B | $2.51B | $2.18B | $8.75B | $1.97B |
| Total Operating Revenue | $2.39B | $2.51B | $2.18B | $8.75B | $1.97B |
| Cost of Revenue | $1.85B | $1.95B | $1.75B | $6.91B | $1.64B |
| Gross Profit | $532.00M | $560.00M | $431.00M | $1.84B | $338.00M |
| Operating Expense | $217.00M | $234.00M | $238.00M | $888.00M | $196.00M |
| Selling and Admin Expenses | $154.00M | $169.00M | $178.00M | $633.00M | $138.00M |
| -General & Admin Expense | $154.00M | $169.00M | – | $633.00M | $138.00M |
| Research & Development | $63.00M | $65.00M | $60.00M | $255.00M | $58.00M |
| Operating Profit | $315.00M | $326.00M | $193.00M | $956.00M | $142.00M |
| Net Non-Operating Interest Income (Expense) | -$56.00M | -$55.00M | -$52.00M | -$208.00M | -$52.00M |
| Non-Operating Interest Income | $2.00M | $2.00M | $2.00M | $11.00M | $2.00M |
| Non-Operating Interest Expense | $58.00M | $57.00M | $54.00M | $219.00M | $54.00M |
| Other Income (Expense) | -$10.00M | -$15.00M | -$5.00M | -$180.00M | -$78.00M |
| Gain on Sale of Security | -$4.00M | -$1.00M | -$1.00M | -$10.00M | -$2.00M |
| Special Income (Charges) | $0.00 | -$1.00M | -$9.00M | -$96.00M | -$54.00M |
| -Less:Restructuring and Mergern & Acquisition | $0.00 | $1.00M | $9.00M | $63.00M | $21.00M |
| -Less:Write Off | $0.00 | – | – | – | – |
| Other Non-Operating Income (Expenses) | -$6.00M | -$13.00M | $5.00M | -$74.00M | -$22.00M |
| Pretax Profit | $249.00M | $256.00M | $136.00M | $568.00M | $12.00M |
| Tax | -$4.00M | $72.00M | $29.00M | $93.00M | -$71.00M |
| Net Profit | $253.00M | $184.00M | $107.00M | $475.00M | $83.00M |
| Profit from Continuing Operations | $253.00M | $184.00M | $107.00M | $475.00M | $83.00M |
| Minority Interests | $1.00M | $1.00M | $0.00 | $1.00M | $0.00 |
| Net Income to Parent Company | $252.00M | $183.00M | $107.00M | $474.00M | $83.00M |
| Net Income to Common Stockholders | $252.00M | $183.00M | $107.00M | $474.00M | $83.00M |
| Basic EPS | $2.21 | $1.60 | $0.93 | $4.14 | $0.93 |
| Diluted EPS | $2.19 | $1.59 | $0.93 | $4.10 | $0.92 |
| Dividend Per Share | $0.84 | $0.84 | $0.84 | $3.33 | $0.84 |
| -Less:Impairment of Capital Assets | – | – | – | $33.00M | – |
| -Gain on Sale Of Business | – | – | – | $0.00 | – |
Balance sheet
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Assets | $15.47B | $15.42B | $15.22B | $14.86B | $14.86B |
| Total Current Assets | $4.37B | $4.26B | $4.06B | $3.65B | $3.65B |
| Cash and Cash Equivalents & Short-Term Investments | $768.00M | $691.00M | $665.00M | $566.00M | $566.00M |
| -Cash and Cash Equivalents | $768.00M | $691.00M | $665.00M | $566.00M | $566.00M |
| Receivables | $1.32B | $1.37B | $1.22B | $999.00M | $999.00M |
| -Accounts Receivable | $1.06B | $1.10B | $949.00M | $737.00M | $737.00M |
| -Other Receivables | $262.00M | $268.00M | $268.00M | $262.00M | $262.00M |
| Inventory | $2.19B | $2.10B | $2.08B | $1.98B | $1.98B |
| Other Current Assets | $87.00M | $98.00M | $96.00M | $100.00M | $100.00M |
| Total Non-Current Assets | $11.10B | $11.17B | $11.17B | $11.21B | $11.21B |
| Net PPE | $5.65B | $5.69B | $5.69B | $5.73B | $5.73B |
| -Gross PPE | $14.71B | $14.64B | $14.55B | $14.51B | $14.51B |
| -Accumulated Depreciation | -$9.06B | -$8.96B | -$8.86B | -$8.78B | -$8.78B |
| Goodwill and Other Intangible Assets | $4.57B | $4.59B | $4.61B | $4.64B | $4.64B |
| -Goodwill | $3.66B | $3.66B | $3.66B | $3.67B | $3.67B |
| -Other Intangible Assets | $905.00M | $924.00M | $946.00M | $970.00M | $970.00M |
| Other Non-Current Assets | $888.00M | $898.00M | $871.00M | $848.00M | $848.00M |
| Total Liabilities | $9.13B | $9.25B | $9.14B | $8.82B | $8.82B |
| Total Current Liabilities | $2.77B | $2.84B | $2.77B | $2.65B | $2.65B |
| Payables | $2.01B | $2.08B | $2.00B | $1.44B | $1.44B |
| -Accounts Payable | $2.01B | $2.08B | $2.00B | $1.21B | $1.21B |
| Short-Term Debt and Capital Lease Obligation | $764.00M | $765.00M | $770.00M | $586.00M | $586.00M |
| -Current Debt | $764.00M | $765.00M | $770.00M | $586.00M | $586.00M |
| Total Non-Current Liabilities | $6.36B | $6.41B | $6.37B | $6.17B | $6.17B |
| Long Term Debt and Capital Lease Obligation | $4.45B | $4.45B | $4.45B | $4.20B | $4.20B |
| -Long Term Debt | $4.45B | $4.45B | $4.45B | $4.20B | $4.20B |
| Non-Current Deferred Liabilities | $740.00M | $685.00M | $680.00M | $669.00M | $669.00M |
| Employee Benefits | $383.00M | $393.00M | $400.00M | $409.00M | $409.00M |
| Other Non-Current Liabilities | $782.00M | $879.00M | $838.00M | $891.00M | $891.00M |
| Total Equity | $6.34B | $6.18B | $6.09B | $6.04B | $6.04B |
| Stockholders' Equity | $6.28B | $6.10B | $6.01B | $5.96B | $5.96B |
| Capital Stock | $2.00M | $2.00M | $2.00M | $2.00M | $2.00M |
| -Common Stock | $2.00M | $2.00M | $2.00M | $2.00M | $2.00M |
| Additional Paid-In Capital | $2.56B | $2.54B | $2.52B | $2.50B | $2.50B |
| Retained Earnings | $10.36B | $10.20B | $10.11B | $10.11B | $10.11B |
| Less: Treasury Stock | -$6.49B | -$6.49B | -$6.49B | -$6.49B | -$6.49B |
| Gains/Losses Not Affecting Retained Earnings | -$152.00M | -$160.00M | -$141.00M | -$160.00M | -$160.00M |
| Minority Interests | $59.00M | $79.00M | $77.00M | $76.00M | $76.00M |
| -Total Tax Payable | – | – | – | $232.00M | $232.00M |
| Current Accrued Expenses | – | – | – | $171.00M | $171.00M |
| Other Current Liabilities | – | – | – | $452.00M | $452.00M |
Cash flow
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Operating Cash Flow | $290.00M | $224.00M | -$137.00M | $970.00M | $502.00M |
| Net cash flow from continuing operations | $290.00M | $224.00M | -$137.00M | $970.00M | $502.00M |
| Net Income from Continuing Operations | $253.00M | $184.00M | $107.00M | $475.00M | $83.00M |
| Depreciation & Depletion & Amortization | $134.00M | $132.00M | $131.00M | $513.00M | $131.00M |
| Deferred Tax | $55.00M | $15.00M | -$5.00M | $141.00M | $102.00M |
| Other Non-Cash Items | $36.00M | $49.00M | -$75.00M | -$82.00M | $6.00M |
| Change in Working Capital | -$188.00M | -$156.00M | -$295.00M | -$104.00M | $153.00M |
| -Change in Receivables | $37.00M | -$147.00M | -$222.00M | $61.00M | $192.00M |
| -Change in Inventory | -$83.00M | -$27.00M | -$119.00M | $24.00M | -$49.00M |
| -Change in Payables and Accrued Expense | -$85.00M | $18.00M | $67.00M | -$76.00M | $199.00M |
| -Change In Other Working Capital | -$57.00M | $0.00 | -$21.00M | – | – |
| Net cash flow from investing | -$96.00M | -$99.00M | -$104.00M | -$462.00M | -$47.00M |
| Net Cash Flow from Continuing Investing Activities | -$96.00M | -$99.00M | -$104.00M | -$462.00M | -$47.00M |
| Net PPE Purchase and Sale | -$95.00M | -$100.00M | -$103.00M | -$546.00M | -$112.00M |
| Net Other Investing Changes | -$1.00M | – | -$1.00M | $46.00M | $27.00M |
| Financing Cash Flow | -$117.00M | -$100.00M | $341.00M | -$797.00M | -$382.00M |
| Net Cash Flow from Continuing Financing Activities | -$117.00M | -$100.00M | $341.00M | -$797.00M | -$382.00M |
| Net Issuance Payments Of Debt | $0.00 | $0.00 | $444.00M | -$304.00M | -$290.00M |
| Net Common Stock Issuance | $0.00 | – | – | -$100.00M | $0.00 |
| Cash Dividends Paid | -$96.00M | -$96.00M | -$96.00M | -$381.00M | -$94.00M |
| Net Other Financing Charges | -$21.00M | -$4.00M | -$7.00M | -$12.00M | $2.00M |
| Ending Cash Balance | $768.00M | $691.00M | $665.00M | $566.00M | $566.00M |
| Net Change in Cash | $77.00M | $25.00M | $100.00M | -$289.00M | $73.00M |
| Beginning Cash Balance | $691.00M | $665.00M | $566.00M | $837.00M | $489.00M |
| Effect of Exchange Rate Changes | $0.00 | $1.00M | -$1.00M | $18.00M | $4.00M |
| Free Cash Flow | $195.00M | $124.00M | -$240.00M | $424.00M | $390.00M |
| Gain/Loss from Continuing Operations | – | – | – | -$6.00M | – |
| -Change in Other Current Assets | – | – | – | $95.00M | – |
| -Change in Other Current Liabilities | – | – | – | -$208.00M | – |
| Net Business Purchase and Sale | – | – | – | $38.00M | – |
No comments yet — be the first to weigh in on EMN.
Sign in to join the discussion.